Effect of systemic administered zoledronic acid on osseointegration of a titanium implant in ovariectomized rats

Abstract Objective The aim of this study was to evaluate whether zoledronic acid improves post-implant osseointegration in an ovariectomized rat model. Materials and methods A total of 36 female Wistar rats were subdivided into three groups: control (CTRL), ovariectomized (OVX) and ovariectomized + ...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cranio-maxillo-facial surgery 2014-10, Vol.42 (7), p.1106-1111
Main Authors: Dikicier, Emre, Karaçaylı, Ümit, Dikicier, Sibel, Günaydın, Yılmaz
Format: Article
Language:English
Subjects:
Animals
Bone Density Conservation Agents - administration & dosage
Bone-Implant Interface - pathology
Dental Implants
Dental Materials - chemistry
Dentistry
Diphosphonates - administration & dosage
Female
Imidazoles - administration & dosage
Implant
Injections, Intravenous
Models, Animal
Osseointegration
Osseointegration - drug effects
Osteoporosis
Ovariectomy
Random Allocation
Rats
Rats, Wistar
Surgery
Tibia - pathology
Tibia - surgery
Time Factors
Titanium - chemistry
Zoledronic acid
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Objective The aim of this study was to evaluate whether zoledronic acid improves post-implant osseointegration in an ovariectomized rat model. Materials and methods A total of 36 female Wistar rats were subdivided into three groups: control (CTRL), ovariectomized (OVX) and ovariectomized + zoledronic acid (OVX/ZOL). Both OVX and OVX/ZOL groups underwent ovariectomy procedures, while the CTRL group received a sham operation. After a 90-day waiting period following surgery, the OVX/ZOL group received a weekly intravenous injection of 0.04 mg/kg zoledronic acid over a period of 6 weeks. The CTRL and OVX groups received intravenous injections of 0.9% NaCl, and the injections were administered with a dosing schedule that was identical to that of the OVX/ZOL group. After completing the 6-week injection regimen, every group received a titanium implant that was 1.6 mm in diameter by 4 mm in length, which was placed in the proximal metaphysis of the left tibia. All of the rats were sacrificed after 60 days and the tibia bones were harvested and processed for histological evaluation. Results The percentage of bone–implant contact (BIC) varied significantly between groups. Histomorphometric analysis demonstrated that BIC was significantly higher in the OVX/ZOL group than in the OVX group. Conclusions Systemic zoledronic acid improved tibial titanium implant osseointegration in an oestrogen-deficient rat model.
ISSN:1010-5182
1878-4119
DOI:10.1016/j.jcms.2014.01.039